Nonmetal Graphdiyne Nanozyme-Based Ferroptosis-Apoptosis Strategy for Colon Cancer Therapy

ACS Appl Mater Interfaces. 2022 Jun 22;14(24):27720-27732. doi: 10.1021/acsami.2c06721. Epub 2022 Jun 8.

Abstract

Ferroptosis-apoptosis, a new modality of induced cell death dependent on reactive oxygen species, has drawn tremendous attention in the field of nanomedicine. A metal-free ferroptosis-apoptosis inducer was reported based on boron and nitrogen codoped graphdiyne (BN-GDY) that possesses efficient glutathione (GSH) depletion capability and concurrently induces ferroptosis by deactivation of GSH-dependent peroxidases 4 (GPX4) and apoptosis by downregulation of Bcl2. The high catalytic activity of BN-GDY is explicated by both kinetic experiments and density functional theory (DFT) calculations of Gibbs free energy change during hydrogen peroxide (H2O2) decomposition. In addition, a unique sequence Bi-Bi mechanism is discovered, which is distinct from the commonly reported ping-pong Bi-Bi mechanism of most peroxidase mimics and natural enzymes. We anticipate that this nonmetal ferroptosis-apoptosis therapeutic concept by carbon-based nanomaterials would provide proof-of-concept evidence for nanocatalytic medicines in cancer therapy.

Keywords: colon cancer; ferroptosis−apoptosis; graphdiyne; metal-free; nanozyme.

MeSH terms

  • Apoptosis
  • Colonic Neoplasms* / drug therapy
  • Ferroptosis*
  • Glutathione / metabolism
  • Graphite
  • Humans
  • Hydrogen Peroxide / metabolism

Substances

  • graphdiyne
  • Graphite
  • Hydrogen Peroxide
  • Glutathione